Pharmaceutical approval update.
Goldenberg MM.
P T · other; journal article PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för tasimelteon. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
13 hitsTasimelteon (Hetlioz) for non-24-hour sleep-wake disorder.
Författaruppgift saknas
Med Lett Drugs Ther · journal articleNew and emerging pharmacotherapeutic approaches for insomnia.
Neubauer DN.
Int Rev Psychiatry · review; journal article · DOI 10.3109/09540261.2014.888990Simeprevir capsules.
Cada DJ, Levien TL, Baker DE.
Hosp Pharm · research-article; journal article · DOI 10.1310/hpj4904-376Tasimelteon approved for circadian disorder in blind adults.
Traynor K.
Am J Health Syst Pharm · news · DOI 10.2146/news140017Tasimelteon: first global approval.
Dhillon S, Clarke M.
Drugs · review; journal article · DOI 10.1007/s40265-014-0200-1MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.
Zlotos DP, Jockers R, Cecon E, Rivara S, Witt-Enderby PA.
J Med Chem · journal article · DOI 10.1021/jm401343cCardiovascular effects of melatonin receptor agonists.
Paulis L, Simko F, Laudon M.
Expert Opin Investig Drugs · research support, non-u.s. gov't; review; journal article · DOI 10.1517/13543784.2012.714771Recent progress in the development of agonists and antagonists for melatonin receptors.
Zlotos DP.
Curr Med Chem · review; journal article · DOI 10.2174/092986712801323153Tasimelteon for insomnia.
Lankford DA.
Expert Opin Investig Drugs · research support, non-u.s. gov't; review; journal article · DOI 10.1517/13543784.2011.583235Tasimelteon, a melatonin agonist for the treatment of insomnia and circadian rhythm sleep disorders.
Hardeland R.
Curr Opin Investig Drugs · journal articleMelatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials.
Rajaratnam SM, Polymeropoulos MH, Fisher DM, Roth T, Scott C, Birznieks G, Klerman EB.
Lancet · clinical trial, phase iii; clinical trial, phase ii; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1016/s0140-6736(08)61812-7Preclinical pharmacokinetics and metabolism of BMS-214778, a novel melatonin receptor agonist.
Vachharajani NN, Yeleswaram K, Boulton DW.
J Pharm Sci · journal article · DOI 10.1002/jps.10348